Arcadia Biosciences
RKDA
13 hedge funds and large institutions have $2.14M invested in Arcadia Biosciences in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
26% more capital inflows, than outflows
Capital inflows: $1.54M | Capital outflows: $1.22M
2.03% more ownership
Funds ownership: 7.18% → 9.2% (+2%)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$978K |
| 2 |
Virtu Financial
New York
|
+$155K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$144K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$117K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$86.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CVI Holdings
Wilmington,
Delaware
|
-$984K |
| 2 |
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$206K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.79K |
| 5 |
Advisor Group
Phoenix,
Arizona
|
-$5.02K |
RKDA Hedge Fund Activity: Q3 2018 in Review
13 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q3 2018, worth a combined $2.14M — down 24% from $2.82M a quarter earlier.
Fund positioning in RKDA was balanced in Q3 2018: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, adding an estimated $978K. The largest seller was CVI Holdings, exiting entirely with an estimated $984K sold.
- 13 institutional investors held Arcadia Biosciences (RKDA) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $2.14M of Arcadia Biosciences stock for Q3 2018, down 24% quarter-over-quarter.
- 4 funds opened new Arcadia Biosciences positions in Q3 2018 and 4 closed out, a net change of 0 holders.
- The largest Arcadia Biosciences buyer in Q3 2018 was Sabby Management, an estimated $978K added.
- The largest Arcadia Biosciences seller in Q3 2018 was CVI Holdings, an estimated $984K sold.
Based on aggregated 13F filings for Q3 2018.